We are live on ! Find out more
BC

Bruce & Co Portfolio holdings

AUM $350M
1-Year Est. Return 33.5%
This Fund
S&P 500
This Quarter Est. Return
+0.66%
1 Year Est. Return
+33.5%
3 Year Est. Return
+65.72%
5 Year Est. Return
+73.85%
10 Year Est. Return
+249.08%
AUM
$308M
AUM Growth
-$3.36M
Cap. Flow
-$1.51M
Cap. Flow %
-0.49%
Top 10 Hldgs %
66.17%
Holding
43
New
1
Increased
2
Reduced
4
Closed
2

Top Buys

Rank Stock Value
1
LYB icon
LyondellBasell Industries
LYB
+$2.33M
2
VICR icon
Vicor
VICR
+$894K
3
CC icon
Chemours
CC
+$563K

Top Sells

Rank Stock Value
1
CMS icon
CMS Energy
CMS
+$2.14M
2
MRK icon
Merck
MRK
+$795K
3
OGN icon
Organon & Co
OGN
+$465K
4
DAR icon
Darling Ingredients
DAR
+$329K
5
FATE icon
Fate Therapeutics
FATE
+$140K

Sector Composition

Rank Sector Weight
1 Utilities 25.12%
2 Healthcare 24.64%
3 Industrials 20.52%
4 Financials 9.15%
5 Communication Services 6.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PSNL icon
26
Personalis
PSNL
$1.61B
$1.66M 0.54%
253,000
– –
LLY icon
27
Eli Lilly
LLY
$1.05T
$1.56M 0.51%
2,000
– –
VG
28
Venture Global Inc
VG
$34.3B
$1.56M 0.51%
100,000
– –
SIRI icon
29
SiriusXM
SIRI
$10.3B
$1.28M 0.42%
55,784
– –
KOD icon
30
Kodiak Sciences
KOD
$2.67B
$1.2M 0.39%
323,000
– –
BHC icon
31
Bausch Health
BHC
$1.8B
$1.14M 0.37%
171,000
– –
FOCL
32
EDAP TMS S.A.
FOCL
$204M
$908K 0.29%
553,652
– –
ASH icon
33
Ashland
ASH
$3.14B
$754K 0.24%
15,000
– –
MNKD icon
34
MannKind Corp
MNKD
$1.25B
$730K 0.24%
195,073
– –
LVTX
35
DELISTED
LAVA Therapeutics
LVTX
$689K 0.22%
521,874
– –
VTRS icon
36
Viatris
VTRS
$20.1B
$520K 0.17%
58,279
– –
MASS icon
37
908 Devices
MASS
$302M
$487K 0.16%
68,286
– –
FATE icon
38
Fate Therapeutics
FATE
$324M
$481K 0.16%
429,188
-120,812
-22% -$140K
WEC icon
39
WEC Energy
WEC
$36.9B
$411K 0.13%
3,945
– –
CRBU icon
40
Caribou Biosciences
CRBU
$164M
$315K 0.1%
250,000
– –
IGMS
41
DELISTED
IGM Biosciences
IGMS
– –
-100,000
Closed -$115K
OGN icon
42
Organon & Co
OGN
$3.55B
– –
-31,200
Closed -$465K
1
2

Similar funds

RFS
Retirement Financial Solutions Knoxville, Tennessee $350M AUM 16.94% 1-Year Est. Return
WMP
Wealth Management Partners Tucson, Arizona $350M AUM 39.2% 1-Year Est. Return
PCM
Pennsylvania Capital Management Huntingdon Valley, Pennsylvania $349M AUM 20.19% 1-Year Est. Return
SA
SRH Advisors Salina, Kansas $349M AUM 10.46% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
KFG
Kingdom Financial Group Peoria, Arizona $349M AUM 12.25% 1-Year Est. Return
LAS
Lloyd Advisory Services Suwanee, Georgia $349M AUM 13.97% 1-Year Est. Return
GAA
Global Assets Advisory Orlando, Florida $349M AUM 24.2% 1-Year Est. Return

Bruce & Co's Q2 2025 Portfolio in Review

As of Q2 2025, Bruce & Co held 43 positions worth $308M, down 1.1% from $312M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Bruce & Co's Q2 2025 filing shows 1 new, 2 increased, 4 reduced and 2 closed positions. Its largest new stake was LyondellBasell Industries: 40,000 shares worth $2.31M. The largest sale was CMS Energy, an estimated $2.14M.

By sector, the portfolio is most concentrated in Utilities at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Industrials.

  • Bruce & Co's largest Q2 2025 buy was LyondellBasell Industries: 40,000 shares worth $2.31M.
  • Bruce & Co added most to Vicor in Q2 2025, an estimated $894K increase.
  • Bruce & Co's biggest Q2 2025 reduction was CMS Energy, cutting an estimated $2.14M.
  • Bruce & Co fully exited Organon & Co in Q2 2025, selling an estimated $465K.
  • Bruce & Co's ten largest holdings make up 66% of its $308M portfolio in Q2 2025.
  • Bruce & Co opened 1 new position and closed 2 in Q2 2025.
  • Bruce & Co's portfolio value fell 1.1% quarter-over-quarter to $308M.

Based on Bruce & Co's 13F filing for Q2 2025, filed 14 Aug 2025.